Massive Growth of +6.4% CAGR for North America Diabetes Care Devices Market by 2023: Top Key Players- ABBOTT, ACON LABORATORIES, BAYER AG, BECTON, DICKINSON AND COMPANY, ELI LILLY & CO., F. HOFFMANN-LA ROCHE, JOHNSON AND JOHNSON

The North America diabetes care devices market is expected to register a CAGR of about 6.4% during 2018-2023 (the forecast period). The United States is anticipated to dominate the market during the forecast period, owing to the growing prevalence of obesity in the country.

Detailed Sample Copy of Updated Analysis @ https://marketprognosis.com/sample-request/16980
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Growing Epidemic of Obesity in the US
Obesity is one of the most challenging health crises in the United States, which is affecting the US diabetes care devices market. Twenty years ago, none of the states in the United States had an obesity rate of over 15%. However, at present, only Colorado has an obesity rate below 20%. The Southern states are witnessing the highest rates of obesity. Moreover, Mississippi tops the list, where nearly 34% of the population is obese. State by state, the obesity rates gets higher. The increasing obesity rate is affecting the prevalence of diabetes among the regional population, which is likely to be a driving factor for the market for diabetes care devices in the region. The rising awareness, regarding diabetic care, growing healthcare expenditure, and technological advancements are further driving the market for diabetes care devices in North America.

Key Developments in the Market
• March 2018: Medtronic PLC received the US Food and Drug Administration (FDA) approval for the Guardian(TM) Connect continuous glucose monitoring (CGM) system, for diabetics aged between 14-75 years.
• January 2018: Abbott announced that the FreeStyleLibre System, the company's revolutionary new continuous glucose monitoring (CGM) system, is now available to Medicare patients in the United States.

Major Players:
ABBOTT, ACON LABORATORIES, INC., BAYER AG, BECTON, DICKINSON AND COMPANY, ELI LILLY & CO., F. HOFFMANN-LA ROCHE LTD, JOHNSON AND JOHNSON, MEDTRONIC PLC, NOVO NORDISK A/S, AND SANOFI, amongst others.

Get Quality Discount @ https://marketprognosis.com/discount-request/16980
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

Low Patient Compliance
The rate of adoption of highly advanced devices to the number of incidences of diabetes is not proportionate in the developing countries, like Mexico. The low adoption rate for diabetes care devices can be attributed to the public unwillingness for regular checkups. As diabetes is not a severely pain-causing or instantly life-threatening disease, people seldom take it seriously and keep a check on their blood glucose levels regularly. According to the International Diabetes Federation, as of 2014, the number of undiagnosed diabetes adults reached nearly 4 million. Over one-fifth of the population lives in the rural areas, where awareness, regarding diseases, availability of technology, and related treatments are negligible. The public unwillingness toward regular checkups, along with low awareness regarding technological advancements, and a highly competitive market are the major factors restraining the market.

The US to Dominate the Market
In North America, the United States dominates the diabetes care devices market. Increasing prevalence of diabetes, caused by rapid urbanization and sedentary lifestyles, is a major factor attributing to this growth. The United States is anticipated to grow tremendously during the forecast period and remain occupying the highest share of the North America diabetes care devices market. This growth can be attributed to the factors, like a high prevalence of diabetes, growing obese population, and government initiatives in creating awareness, regarding diabetes care and preventive diagnosis.

Browse Report @ https://marketprognosis.com/enquiry/16980
Note: “If this link doesn’t work in Internet Explorer, kindly try copy pasting it in other browsers”.

About Market Prognosis
We at Market Prognosis believe in giving a crystal clear view of market dynamics for achieving success in today’s complex and competitive marketplace through our quantitative & qualitative research methods.
We help our clients identify the best market insights and analysis required for their business thus enabling them to take strategic and intelligent decision.
We believe in delivering actionable insights for your business growth and success.

Contact us:
ProgMarkPvt Ltd,
Thane - 421501
India.
Contact No: +1 973 241 5193
Email: sales@marketprognosis.com

This release was published on openPR.